More recent studies [3,4], including our previous analyses from the Long Island Breast Cancer Study Project [5], demonstrated that use of aspirin (the most commonly used NSAID) is associated with a significant reduction in risk for breast cancer, especially for hormone receptor positive tumors. Here, NR4A1 is linked to breast cancer.